Aspire Biopharma Holdings (ASBP) Non-Current Deffered Revenue (2022 - 2024)
Aspire Biopharma Holdings' (ASBP) quarterly Non-Current Deffered Revenue came in at $5.0 million in Q4 2024, up 566.67% on a QoQ basis from $750000.0 in Q3 2023.
Aspire Biopharma Holdings (ASBP) Non-Current Deffered Revenue (2022 - 2024) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 3 years of Non-Current Deffered Revenue data on file, last reported at $5.0 million in Q4 2024.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $5.0 million in Q4 2024; TTM through Dec 2024 was $5.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $5.0 million, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q4 2024 stood at $5.0 million, up from $750000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for ASBP reached as high as $5.0 million in Q1 2022 and fell as low as $750000.0 in Q2 2022.
- Historically, Non-Current Deffered Revenue has averaged $2.3 million across 3 years, with a median of $750000.0 in 2022.
- On a YoY basis, Non-Current Deffered Revenue climbed as much as 0.0% in 2023 and fell as far as 85.0% in 2023.
- Year by year, Non-Current Deffered Revenue stood at $750000.0 in 2022, then changed by 0.0% to $750000.0 in 2023, then jumped by 566.67% to $5.0 million in 2024.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $5.0 million in Q4 2024, $750000.0 in Q3 2023, and $750000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2023 | 750,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 750,000.00 |
| Mar 31, 2022 | 5.00 Mn |